Orange Book product · Brand (NDA)
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
MEROPENEM
At a glance
Apr 30, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 30, 2015
11 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
MEROPENEM
Strength
1GM/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 202106
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2023MEROPENEMBrand (NDA)
NDA 215212 · HQ SPCLT PHARMA
- 1996MERREM IVBrand (NDA)
NDA 050706 · PFIZER
- 2025MEROPENEMGeneric (ANDA)
ANDA 219084 · BROOKS STERISCIENCE
- 2024MEROPENEMGeneric (ANDA)
ANDA 216424 · QILU
- 2022MEROPENEMGeneric (ANDA)
ANDA 216154 · BROOKS STERISCIENCE
- 2019MEROPENEMGeneric (ANDA)
ANDA 210773 · HQ SPCLT PHARMA
- 2017MEROPENEMGeneric (ANDA)
ANDA 205835 · EUGIA PHARMA
- 2016MEROPENEMGeneric (ANDA)
ANDA 204139 · ACS DOBFAR SPA
- 2016MEROPENEMGeneric (ANDA)
ANDA 206141 · GLAND
- 2016MEROPENEMGeneric (ANDA)
ANDA 206086 · SAVIOR LIFETEC CORP
- 2016MEROPENEMGeneric (ANDA)
ANDA 205883 · AMNEAL PHARMS
- 2015MEROPENEMGeneric (ANDA)
ANDA 204854 · DAEWOONG PHARM CO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
